Simulations Plus, Inc.
SLPSimulations Plus, Inc. (SLP) is a software company specializing in developing pharmacometric and pharmacokinetic modeling and simulation tools for the pharmaceutical, biotech, and health care industries. Founded in 1996, the company provides solutions that aid in drug discovery, development, and regulatory approval processes, with a focus on optimizing clinical trial design and understanding drug behavior. Its flagship products include GastroPlus, ABLAs, and other modeling platforms used by scientists and researchers worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 5, 2024 | $0.06 | 2024-07-29 | 2024-07-29 |
| May 6, 2024 | $0.06 | 2024-04-26 | 2024-04-29 |
| February 5, 2024 | $0.06 | 2024-01-26 | 2024-01-29 |
| November 6, 2023 | $0.06 | 2023-10-27 | 2023-10-30 |
| August 7, 2023 | $0.06 | 2023-07-28 | 2023-07-31 |
Dividends Summary
- Consistent Payer: Simulations Plus, Inc. has rewarded shareholders with 51 dividend payments over the past 12 years.
- Total Returned Value: Investors who held SLP shares during this period received a total of $2.87 per share in dividend income.
- Latest Payout: The most recent dividend of $0.06/share was paid 712 days ago, on August 5, 2024.
- Yield & Schedule: SLP currently pays dividends quarterly with an annual yield of 1.32%.
- Dividend Growth: Since 2012, the dividend payout has grown by 20.0%, from $0.05 to $0.06.
- Dividend Reliability: SLP has maintained or increased its dividend for 46 consecutive payments.
Company News
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The investigations concern whether shareholders are receiving fair consideration in these transactions, with concerns that insiders may benefit dispro...
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholders' inte...
The global in silico clinical trials market, valued at USD 1.84 billion in 2025, is projected to grow to USD 8.94 billion by 2035 at a 15.2% CAGR. Growth is driven by high failure rates in traditional clinical trials, regulatory acceptance of computational evidence, advances in AI and digital twins, and ethical concerns about animal testing. Nort...
Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties. AstroNova is being acquired by Arcline Investment Management for $29.00 per share, Simulations Plus is being sold to Altaris affiliates for $18.50 per share, and Olin Corporation is merging with...
The DJS Law Group has announced an investigation into Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors, focusing on whether the company issued misleading statements or failed to disclose material information to investors. The law group is seeking shareholders who suffered losses to participate in the investigation.
